Approval · Notice of Compliance 9564 · 2008
APO-VALACYCLOVIR: Notice of Compliance 9564
Issued May 23, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9564
- Date
- May 23, 2008
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antiviral agent
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-VALACYCLOVIR | 02295822 | Marketed |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 500 MG per TAB